Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

Comparative efficacy between atorvastatin and rosuvastatin in the prevention of cardiovascular disease recurrence.

Perez-Calahorra S, Laclaustra M, Marco-Benedi V, Pinto X, Sanchez-Hernandez RM, Plana N, Ortega E, Fuentes F, Civeira F.

Lipids Health Dis. 2019 Dec 11;18(1):216. doi: 10.1186/s12944-019-1153-x.

2.

Evaluation of microvascular changes in the perifoveal vascular network using optical coherence tomography angiography (OCTA) in type I diabetes mellitus: a large scale prospective trial.

Zarranz-Ventura J, Barraso M, Alé-Chilet A, Hernandez T, Oliva C, Gascón J, Sala-Puigdollers A, Figueras-Roca M, Vinagre I, Ortega E, Esmatjes E, Adan A.

BMC Med Imaging. 2019 Nov 21;19(1):91. doi: 10.1186/s12880-019-0391-8.

3.

Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: Prescription According to Reimbursement Constraints and Guideline Recommendations in Catalonia.

Franch-Nadal J, Mata-Cases M, Ortega E, Real J, Gratacòs M, Vlacho B, Vallés JA, Mauricio D.

J Clin Med. 2019 Sep 5;8(9). pii: E1389. doi: 10.3390/jcm8091389.

4.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators.

Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9.

PMID:
31189511
5.

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators.

Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9.

PMID:
31189509
6.

Glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes:real-world evidence from a Mediterranean area.

Mata-Cases M, Franch-Nadal J, Ortega E, Real J, Gratacòs M, Vlacho B, Mauricio D.

Curr Med Res Opin. 2019 Oct;35(10):1735-1744. doi: 10.1080/03007995.2019.1618806. Epub 2019 Jun 17.

PMID:
31081693
7.

Prevalence and factors associated with statin use in high-risk patients with type 1 diabetes from a specialized diabetes unit.

Amor AJ, Ortega E, Giménez M, Cofán M, Blanco J, Pané A, Boswell L, Vinagre I, Esmatjes E, Conget I.

Endocrinol Diabetes Nutr. 2019 Oct;66(8):512-519. doi: 10.1016/j.endinu.2019.02.004. Epub 2019 Apr 15. English, Spanish.

PMID:
31000451
8.

Ultrasound Tissue Characterization of Carotid Plaques Differs Between Patients with Type 1 Diabetes and Subjects without Diabetes.

Castelblanco E, Betriu À, Hernández M, Granado-Casas M, Ortega E, Soldevila B, Ramírez-Morros A, Franch-Nadal J, Puig-Domingo M, Fernández E, Avogaro A, Alonso N, Mauricio D.

J Clin Med. 2019 Mar 28;8(4). pii: E424. doi: 10.3390/jcm8040424.

9.

Ambient temperature and prevalence of diabetes and insulin resistance in the Spanish population: Di@bet.es study.

Valdés S, Doulatram-Gamgaram V, Lago A, García Torres F, Badía-Guillén R, Olveira G, Goday A, Calle-Pascual A, Castaño L, Castell C, Delgado E, Menendez E, Franch-Nadal J, Gaztambide S, Girbés J, Gomis R, Ortega E, Galán-García JL, Aguilera-Venegas G, Soriguer F, Rojo-Martínez G.

Eur J Endocrinol. 2019 May 1;180(5):273-280. doi: 10.1530/EJE-18-0818.

PMID:
30840583
10.

Ten-year outcomes after Roux-en-Y gastric bypass and sleeve gastrectomy: an observational nonrandomized cohort study.

Jiménez A, Ibarzabal A, Moizé V, Pané A, Andreu A, Molero J, de Hollanda A, Flores L, Ortega E, Lacy A, Vidal J.

Surg Obes Relat Dis. 2019 Mar;15(3):382-388. doi: 10.1016/j.soard.2019.01.020. Epub 2019 Jan 29.

PMID:
30772254
11.

Effects of sex steroids on cardiovascular risk profile in transgender men under gender affirming hormone therapy.

Aranda G, Mora M, Hanzu FA, Vera J, Ortega E, Halperin I.

Endocrinol Diabetes Nutr. 2019 Jun - Jul;66(6):385-392. doi: 10.1016/j.endinu.2018.11.004. Epub 2019 Jan 28. English, Spanish.

PMID:
30704917
12.

Obesity and Alzheimer's disease, does the obesity paradox really exist? A magnetic resonance imaging study.

Pegueroles J, Jiménez A, Vilaplana E, Montal V, Carmona-Iragui M, Pané A, Alcolea D, Videla L, Casajoana A, Clarimón J, Ortega E, Vidal J, Blesa R, Lleó A, Fortea J; Alzheimer's Disease Neuroimaging Initiative.

Oncotarget. 2018 Oct 5;9(78):34691-34698. doi: 10.18632/oncotarget.26162. eCollection 2018 Oct 5.

13.

Genetic background influences weight-loss trajectories on the mid-term after bariatric surgery.

Boswell L, Jiménez A, Ortega E, Pané A, Hollanda A, Moizé V, Andreu A, Ibarzabal A, Flores L, Vidal J.

Int J Obes (Lond). 2019 Sep;43(9):1869-1874. doi: 10.1038/s41366-018-0229-4. Epub 2018 Oct 9.

PMID:
30301966
14.

Health care and therapeutic education program for newly diagnosed type 2 diabetes: A new approach in primary care.

Colungo C, Liroz M, Jansà M, Blat E, Herranz MC, Vidal M, García E, Gómez M, Esmatjes E, Ortega E.

Endocrinol Diabetes Nutr. 2018 Nov;65(9):486-499. doi: 10.1016/j.endinu.2018.06.011. Epub 2018 Aug 23. English, Spanish.

PMID:
30145266
15.

Diabetes mellitus and cardiovascular risk: Update of the recommendations of the Diabetes and Cardiovascular Disease working group of the Spanish Diabetes Society (SED, 2018).

Arrieta F, Iglesias P, Pedro-Botet J, Becerra A, Ortega E, Obaya JC, Nubiola A, Maldonado GF, Campos MDM, Petrecca R, Pardo JL, Sánchez-Margalet V, Alemán JJ, Navarro J, Duran S, Tébar FJ, Aguilar M, Escobar F; Grupo de Riesgo Cardiovascular de la Sociedad Española de Diabetes (SED).

Clin Investig Arterioscler. 2018 May - Jun;30(3):137-153. doi: 10.1016/j.arteri.2018.03.002. Epub 2018 May 10. English, Spanish.

PMID:
29754804
16.

Iron deficiency is associated with Hypothyroxinemia and Hypotriiodothyroninemia in the Spanish general adult population: Di@bet.es study.

Maldonado-Araque C, Valdés S, Lago-Sampedro A, Lillo-Muñoz JA, Garcia-Fuentes E, Perez-Valero V, Gutierrez-Repiso C, Goday A, Urrutia I, Peláez L, Calle-Pascual A, Castaño L, Castell C, Delgado E, Menendez E, Franch-Nadal J, Gaztambide S, Girbés J, Ortega E, Vendrell J, Chacón MR, Chaves FJ, Soriguer F, Rojo-Martínez G.

Sci Rep. 2018 Apr 26;8(1):6571. doi: 10.1038/s41598-018-24352-9.

17.

Dietary polyunsaturated fatty acids mediate the inverse association of stearoyl-CoA desaturase activity with the risk of fatty liver in dyslipidaemic individuals.

Amor AJ, Cofán M, Mateo-Gallego R, Cenarro A, Civeira F, Ortega E, Ros E, Sala-Vila A.

Eur J Nutr. 2019 Jun;58(4):1561-1568. doi: 10.1007/s00394-018-1691-4. Epub 2018 Apr 19.

PMID:
29675558
18.

Correction to: Type 2 diabetes-associated carotid plaque burden is increased in patients with retinopathy compared to those without retinopathy.

Alonso N, Traveset A, Rubinat E, Ortega E, Alcubierre N, Sanahuja J, Hernández M, Betriu A, Jurjo C, Fernández E, Mauricio D.

Cardiovasc Diabetol. 2018 Apr 5;17(1):49. doi: 10.1186/s12933-018-0696-x.

19.

Relationship Between Total Serum Bilirubin Levels and Carotid and Femoral Atherosclerosis in Familial Dyslipidemia.

Amor AJ, Ortega E, Perea V, Cofán M, Sala-Vila A, Nuñez I, Gilabert R, Ros E.

Arterioscler Thromb Vasc Biol. 2017 Dec;37(12):2356-2363. doi: 10.1161/ATVBAHA.117.310071. Epub 2017 Oct 26.

PMID:
29074587
20.

How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition?

Masana L, Plana N, Pérez-Calahorra S, Ibarretxe D, Lamiquiz-Moneo I, Pedro-Botet J, Suárez-Tembra M, Valdivielso P, Ortega E, Civeira F; Dyslipidemia Registry of the Spanish Arteriosclerosis Society.

Atherosclerosis. 2017 Jul;262:107-112. doi: 10.1016/j.atherosclerosis.2017.05.013. Epub 2017 May 12.

PMID:
28531826

Supplemental Content

Loading ...
Support Center